JP2025506671A5 - - Google Patents
Info
- Publication number
- JP2025506671A5 JP2025506671A5 JP2024547937A JP2024547937A JP2025506671A5 JP 2025506671 A5 JP2025506671 A5 JP 2025506671A5 JP 2024547937 A JP2024547937 A JP 2024547937A JP 2024547937 A JP2024547937 A JP 2024547937A JP 2025506671 A5 JP2025506671 A5 JP 2025506671A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- solvent
- contact
- brought
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20220100151 | 2022-02-18 | ||
| GR20220100151 | 2022-02-18 | ||
| EP22167032.6 | 2022-04-06 | ||
| EP22167032 | 2022-04-06 | ||
| EP22178413 | 2022-06-10 | ||
| EP22178413.5 | 2022-06-10 | ||
| PCT/EP2023/054043 WO2023156599A1 (en) | 2022-02-18 | 2023-02-17 | Synthesis of bruton's tyrosine kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506671A JP2025506671A (ja) | 2025-03-13 |
| JP2025506671A5 true JP2025506671A5 (enExample) | 2026-02-18 |
Family
ID=85227338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547937A Pending JP2025506671A (ja) | 2022-02-18 | 2023-02-17 | ブルトン型チロシンキナーゼ阻害剤の合成 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250163076A1 (enExample) |
| EP (1) | EP4479405A1 (enExample) |
| JP (1) | JP2025506671A (enExample) |
| KR (1) | KR20240148351A (enExample) |
| AU (1) | AU2023221549A1 (enExample) |
| CA (1) | CA3252338A1 (enExample) |
| CL (1) | CL2024002409A1 (enExample) |
| CO (1) | CO2024011229A2 (enExample) |
| IL (1) | IL314902A (enExample) |
| JO (1) | JOP20240182A1 (enExample) |
| MX (1) | MX2024010134A (enExample) |
| PE (1) | PE20242069A1 (enExample) |
| WO (1) | WO2023156599A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112023025459A2 (pt) | 2021-06-04 | 2024-02-27 | Janssen Pharmaceutica Nv | Inibidores da tirosina quinase de bruton e métodos de uso dos mesmos |
| WO2025262118A1 (en) * | 2024-06-20 | 2025-12-26 | Janssen Pharmaceutica Nv | Combination therapy using a malt1 inhibitor and a btk inhibitor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3794B1 (ar) * | 2015-12-10 | 2021-01-31 | Janssen Pharmaceutica Nv | المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون |
| WO2018103060A1 (en) * | 2016-12-09 | 2018-06-14 | Janssen Pharmaceutica Nv | Inhibitors of bruton's tyrosine kinase and methods of their use |
-
2023
- 2023-02-17 AU AU2023221549A patent/AU2023221549A1/en active Pending
- 2023-02-17 CA CA3252338A patent/CA3252338A1/en active Pending
- 2023-02-17 PE PE2024001734A patent/PE20242069A1/es unknown
- 2023-02-17 MX MX2024010134A patent/MX2024010134A/es unknown
- 2023-02-17 EP EP23705025.7A patent/EP4479405A1/en active Pending
- 2023-02-17 WO PCT/EP2023/054043 patent/WO2023156599A1/en not_active Ceased
- 2023-02-17 JP JP2024547937A patent/JP2025506671A/ja active Pending
- 2023-02-17 IL IL314902A patent/IL314902A/en unknown
- 2023-02-17 US US18/838,678 patent/US20250163076A1/en active Pending
- 2023-02-17 KR KR1020247027226A patent/KR20240148351A/ko active Pending
-
2024
- 2024-08-12 CL CL2024002409A patent/CL2024002409A1/es unknown
- 2024-08-14 JO JOJO/P/2024/0182A patent/JOP20240182A1/ar unknown
- 2024-08-20 CO CONC2024/0011229A patent/CO2024011229A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102559870B1 (ko) | 카르밤산염 화합물의 제조방법 | |
| RU2762891C2 (ru) | Способы получения цитотоксических производных бензодиазепина | |
| IL314902A (en) | Synthesis of bruton's tyrosine kinase inhibitors | |
| RU2272036C2 (ru) | Способ получения мезилатов производных пиперазина | |
| JP4390861B2 (ja) | アクリジン誘導体多剤耐性阻害薬の合成 | |
| JP4549531B2 (ja) | １，３−二置換−４−オキソ環式尿素の製造方法 | |
| CN110283096A (zh) | 一种Cu-MOF催化的ɑ-胺基酰胺类化合物及其制备方法 | |
| CN112272665A (zh) | 制备立他司特的方法 | |
| JP2019534299A (ja) | （ｓ）−ｎ１−（２−アミノエチル）−３−（４−アルコキシフェニル）プロパン−１，２−ジアミン三塩酸塩の製造方法 | |
| JP4688292B2 (ja) | 純粋な鏡像体であるｎ−メチル−ｎ−［（１ｓ）−１−フェニル−２−（（３ｓ）−３−ヒドロキシピロリジン−１−イル）エチル］−２，２−ジフェニルアセトアミドの製造方法 | |
| EP4414362A1 (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| JP4514950B2 (ja) | １，３−二置換−４−オキソ環式尿素の製造方法 | |
| TW202604910A (zh) | 用於產生二氮雜螺內醯胺化合物之方法及中間物 | |
| JP2003048879A (ja) | 蛍光性基含有カルボジイミド化合物及び該化合物の製造方法 | |
| AU2018311521A1 (en) | Process for preparing 1 -(((Z)-(1 -(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-y l)methyl)-1 -sulfoazetidin-3- yl)amino)ethylidene)amino)oxy)cyclopropane carboxylic acid | |
| CN115850146A (zh) | 一种合成大麻素半抗原化合物及其制备方法和用途 | |
| CN116730861A (zh) | 氧代吡啶类化合物的新型制备方法及关键中间体 | |
| KR20220145631A (ko) | 시타글립틴 인산염의 개선된 제조방법 | |
| JP2001097933A (ja) | 光学活性２−アミノシクロヘキサノール誘導体の製造法 | |
| KR101137503B1 (ko) | 고분자 고체 지지체를 이용한 히스티딜-프롤린아미드 유도체의 제조 방법 | |
| CN110092748B (zh) | 一种手性吡啶磺酰酯类化合物及其制备方法和应用 | |
| CN102149675B (zh) | 用于免疫佐剂E6020之合成前体的β-酮酰胺合成的试剂和方法 | |
| CN120682143A (zh) | 一种芳基并吡啶酮类化合物及其制备方法与应用 | |
| HK40111936A (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| JP2002265481A (ja) | 高分子担持光学活性ホスフィン化合物 |